Resources

In patients with hypertension and Type 2 diabetes, relatively modest improvements in fitness status significantly reduce mortality risk, according to a study…. 

A research team led by a scientist at the Mayo Clinic campus in Florida has developed a molecule that can block the breakdown of insulin in the body. The discovery could lead to new ways of treating diabetes….

People with diabetes who have limited health literacy are at higher risk for hypoglycemia or low blood sugar, according to a new study.…

Patients with higher fasting plasma glucose levels but within the normoglycemic range before kidney transplantation are at increased risk for developing new-onset diabetes after transplantation, according to recent research….

Women with Type 2 diabetes who ate more than 9 g of bran per day had a 35% lower risk for death from cardiovascular disease and a 28% lower risk for all-cause mortality compared with women who ate less bran, according to new study findings….

The aim of this study was to examine differences between adolescents and adults in persistence of the benefits of intensive therapy 10 years after completion of the Diabetes Control and Complications Trial (DCCT)….

People with diabetes have an increased risk of blindness, yet nearly half of the approximately 23 million Americans with diabetes do not get an annual eye exam to detect possible problems. New methods can now help in screening for retinopathy…. 

Researchers are warning that, drinking two or more soft drinks a week can nearly double a person’s risk of developing pancreatic cancer…. 

Lindsey Harris, PharmD Candidate, University of Florida   The doughnut hole has been an issue for Medicare beneficiaries for many years. The costs of drugs have many Part D beneficiaries thrown into a coverage gap that is very expensive, forcing some to go without needed medications. The Obama administration announced …

  The V-G® is a simple-to-use, once-daily, disposable insulin delivery device that provides a preset basal rate and on-demand bolus dosing for mealtime coverage via a mealtime insulin. The V-Go enables millions suffering from type 2 diabetes to conveniently and discreetly deliver insulin throughout the day, bolus dosing on-demand around …